Home › Funds › OBERWEIS ASSET MANAGEMENT INC/ › GMED
OBERWEIS ASSET MANAGEMENT INC/ position in GMED
GLOBUS MED INC · Health Care
OBERWEIS ASSET MANAGEMENT INC/ reported holding 413,630 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$31.0M, representing 0.70% of its reported portfolio and ranking #44 among its reported holdings. OBERWEIS ASSET MANAGEMENT INC/ has disclosed GMED holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How OBERWEIS ASSET MANAGEMENT INC/'s GMED position evolved
OBERWEIS ASSET MANAGEMENT INC/ first disclosed a stake in GMED in Q4 2025 at 270,000 shares (US$23.6M). The position peaked in Q2 2026 at 512,100 shares, worth US$40.5M. Across 4 filings, OBERWEIS ASSET MANAGEMENT INC/ increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 413,630 shares valued at US$31.0M — a reduction of -98,470 shares quarter over quarter.. Notable position changes include a 45% increase in Q1 2026 (shares fell 8% over the following quarter), a 31% increase in Q2 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 270.00K | $23.57M | New |
| Q1 2026 | 392.20K | $33.79M | Add |
| Q2 2026 | 512.10K | $40.46M | Add |
| Q3 2026 | 413.63K | $30.98M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMED and 13F data
GMED (GLOBUS MED INC) is a Health Care company. 36 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$239.4M), Boston Trust Walden Corp (US$123.1M), GW&K Investment Management, LLC (US$110.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMED
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 3.20M sh · $239.44M · Q3 2026
- Boston Trust Walden Corp 1.64M sh · $123.07M · Q3 2026
- GW&K Investment Management, LLC 1.47M sh · $110.29M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.25M sh · $93.58M · Q3 2026
- Clark Capital Management Group, Inc. 1.18M sh · $88.22M · Q3 2026
More on OBERWEIS ASSET MANAGEMENT INC/
FAQ
How long has OBERWEIS ASSET MANAGEMENT INC/ held GMED?
OBERWEIS ASSET MANAGEMENT INC/ has disclosed GMED holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is OBERWEIS ASSET MANAGEMENT INC/'s current position in GMED?
As of Q3 2026, OBERWEIS ASSET MANAGEMENT INC/ holds 413.63K shares of GMED (GLOBUS MED INC), valued at $30.98M, representing 0.70% of its reported portfolio and ranking #44.
Has OBERWEIS ASSET MANAGEMENT INC/ been buying or selling GMED?
In the latest 13F filing (Q3 2026), OBERWEIS ASSET MANAGEMENT INC/ reduced its position in GMED. The position peaked in Q2 2026 at 512.10K shares.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Boston Trust Walden Corp, GW&K Investment Management, LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.